GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Accelrys, Inc. (ACCL) [hlAlert]

Rating:
Market Perform
ACCL

Accelrys, Inc. (ACCL) downgraded to Market Perform by Northland Securities

Posted on: Friday,  Nov 4, 2011  9:25 AM ET by Northland Securities

Northland Securities rated Market Perform Accelrys, Inc. (NASDAQ: ACCL) on 11/04/2011. Previously Northland Securities rated Outperform Accelrys,
Inc. (NASDAQ: ACCL) on 02/07/2008., when the stock price was $6.42. Since then, Accelrys, Inc. has lost 2.65% of its value until Northland Securities rated ACCL Outperform on 11/04/2011, when the price was $6.25. .

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2012 8:25 AM Buy
None
7.81 10.00
as of 12/30/2011
1 Week   
1 Month   
3 Months up  3.13 %
1 YTD down  -24.69 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/4/2011 9:25 AM Hold
None
6.25
2/7/2008 9:25 AM Buy
None
6.42 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy